Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Depreciation and Depletion (2025 - 2026)

Updated

Odyssey Therapeutics (ODTX) reported Depreciation and Depletion of $900,000 for Q3 2026, down 18.2% from $1.1 million a year earlier and unchanged from the prior quarter.

Analysis

Odyssey Therapeutics (ODTX) Depreciation and Depletion (2025 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Odyssey Therapeutics' Depreciation and Depletion came in at $3.9 million.

  • Five-year quarterly Depreciation and Depletion spans a low of $900,000 in Q2 2026 and a high of $1.2 million in Q1 2025.
  • Year over year, Depreciation and Depletion has now declined in each of the last three quarters.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 192.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - 900,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 900,000.00
Jun 30, 2026 900,000.00
Mar 31, 2026 1.00 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 1.20 Mn
API Access

Odyssey Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ODTX&period=max&api_key=YOUR_API_KEY